MET and hepatocellular carcinoma: First, although we found that MetFab-DOX could inhibit the tumor growth in HCC tumor with c-Met expression model, we have not evaluated the actual effect of the ADC against human c-Met-negative cells as well as nonneoplastic c-Met-positive cells as control.